Clinical Predictors of Relapse in a Cohort of Steroid-Treated Patients With Well-Controlled Myasthenia Gravis

Clinical Predictors of Relapse in a Cohort of Steroid-Treated Patients With Well-Controlled Myasthenia Gravis

ObjectiveDespite the high efficiency of glucocorticoids (GCs), ~18–34% patients with myasthenia gravis (MG) may experience relapses of the disease. Here, we aim to identify clinical factors related to relapses during steroid tapering or after withdrawal in MG patients who were well-managed on steroi...

Full description

Bibliographic Details
Main Authors: Shengyao Su, Lin Lei, Zhirong Fan, Shu Zhang, Qi Wen, Jingsi Wang, Yan Lu, Li Di, Min Wang, Hai Chen, Yuwei Da
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-02-01
Series:Frontiers in Neurology
Subjects:
myasthenia gravis
relapse
steroid monotherapy
clinical predictor
steroid reduction
steroid withdrawal
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2022.816243/full

Internet

https://www.frontiersin.org/articles/10.3389/fneur.2022.816243/full

Similar Items